Concepedia

Amy Berwick

AB

Statistics

Publications

3

Citations

131

H-Index

3

Active since

2013

Affiliations

Novartis Institutes for BioMedical Research(Current)

Novartis (Switzerland)

Amy Berwick is an author at Novartis Institutes for BioMedical Research specializing in medicine, immunology, and immunotherapy.

Publications per year

2013–2021

3

Publications

3

Activin Type II Receptor Blockade for Treatment of Muscle Depletion in Chronic Obstructive Pulmonary Disease. A Randomized Trial

Michael I. Polkey, Jens Præstgaard, Amy Berwick et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 103 citations · Full text

Medicine, Immunology, Pharmacotherapy +10

Genetic deletion of the adenosine A2A receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain

Athanasios Metaxas, Ream Al‐Hasani, Pamela Farshim et al. · Neuropharmacology · 2013 · 15 citations

Life Sciences, Neuroscience, Pharmacology +16

BET bromodomain inhibitors regulate keratinocyte plasticity

Gabi Schutzius, Christian Kolter, Sebastian Bergling et al. · Nature Chemical Biology · 2021 · 13 citations

Medicine, Dermatology, Molecular Biology +7

1–3 of 3